-
2022-501352-28-00
5
2023-06-07
Severe community-acquired pneumonia (sCAP)
-
2024-516168-27-00
5
2022-11-10
Adult patients with persistent or chronic immune thrombocytopenia
-
2023-509750-58-00
5
2022-09-21
Polycythemia Vera
-
2024-510800-35-00
5
2022-06-17
Relapsed or Refractory Multiple Myeloma (RRMM)
-
2024-516403-16-00
5
2022-04-07
Adult patients with immune thrombocytopenia (ITP) with mild to severe
-
2024-513936-80-00
4
2021-11-12
elderly patients (> 70 years) with CLL or SLL
-
2024-516651-41-00
5
2021-10-08
COPD : chronic obstructive Pulmonary disease
-
2024-513005-31-00
5
2020-06-11
Patients with untreated metastatic Estrogen Receptor positive (ER+), H
-
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
-
2024-514088-25-00
5
2019-10-07
Multiple Myeloma
-
2023-510357-42-00
5
2019-05-22
hormone receptor (HR)-positive, HER2-negative,
early breast cancer (EB
-
2024-513858-29-01
4
2019-02-06
myelodysplastic syndrome with IDH2 mutated
-
2024-513206-65-00
5
2018-08-10
resected squamous cell carcinoma of head and neck
-
2023-509976-40-00
5
2018-05-28
Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
2024-517489-41-00
5
2017-03-27
High-risk stage III colon cancer
-
2024-515846-18-00
7
2016-09-19
Newly diagnosed Diffuse Large B Cell Lymphoma
-
2022-502049-91-00
4
2023-09-26
SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP)
-
2023-505903-22-00
4
2024-07-02
Sepsis associated acute kidney injury
-
2023-509001-76-00
5
2024-07-01
Asthma
-
2022-501952-27-00
5
2024-04-19
Hospital-acquired bacterial pneumonia (HABP), including ventilated HAB
-
2023-505985-28-01
4
2024-03-04
Severe Community-Acquired Pneumonia
-
2024-511755-18-00
5
2022-12-23
Invasive Candidiasis/ Candidemia
-
2024-516021-32-00
5
2022-02-17
Critically ill patients suffering from CIRCI
-
2024-517839-50-00
11
2020-09-20
sepsis